NASDAQ •
Healthcare •
Biotechnology •
Quote as of 06/24/2026 15:05
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization442.48 mln
Float17.87 mln
Earnings Date09/30/2026
Piotroski F-Score
4
/ 9
Borderline
1-Year Forecast
25.80
Transformational upside
Relative Strength
96
/ 100
Top performer
Debt / Equity
0.00
Debt-free
ROE
-31.51
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Benitec Biopharma is a clinical-stage company working to create new treatments based on genetic medicine. Using its proprietary platform, the company develops therapies that can switch off harmful genes while simultaneously introducing healthy replacement genes ? all through a single treatment. Its lead program targets oculopharyngeal muscular dystrophy, a condition that causes progressive difficulty swallowing. The company operates from its headquarters in Hayward, California.
